top of page
gradientForSurfBreak.png

Item List

Newswires
xCures partners with RenovoRx to assist patients in accessing RenovoRx’s TIGeR-PaC study

xCures, Inc. is proud to announce their partnership with RenovoRx, a clinical-stage biopharmaceutical company that focuses on fighting cancer through localized treatment of difficult-to-treat tumors, such as pancreatic adenocarcinoma. Through this collaboration, xCures will help eligible pancreatic cancer patients access a Phase III clinical study entitled, Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine plus Nab-Paclitaxel following Induction with sequential IV Gemcitabine plus Nab-Paclitaxel and Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer (TIGeR-PaC).

Recent Posts

General News

Carlsmed.png

Hospitals Work Through Fallout from CrowdStrike Outage ...

Modern Healthcare

General News

Carlsmed.png

Humana Makes Investment in AI-powered Medicare Enrollment Platform Healthpilot ...

Fierce Healthcare

General News

Carlsmed.png

Healthcare Costs Set to Rise by as Much as 8% in 2025: PwC ...

Fierce Healthcare

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page